Gyre Therapeutics, Inc. Increase (Decrease) in Prepaid Insurance
Gyre Therapeutics, Inc. (GYRE) reported Increase (Decrease) in Prepaid Insurance of $33.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-10-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidInsurance · last filed 2023-10-26
- 2023-09-30: Increase (Decrease) in Prepaid Insurance 9 month $33.00K.
| Period end | Increase (Decrease) in Prepaid Insurance 9 month |
|---|---|
| 2023-09-30 | $33.00K 10-Q · filed 2023-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |